CIHR’s Institute of Infection & Immunity (III) engaged Shift Health to support the development of a 5-year strategic plan that reflected the research interests and strengths of Canada’s infection and immunity research community and the implications of the COVID-19 pandemic.
With an urgent need to integrate and improve public health efforts across the Gulf region—an imperative amplified by the COVID-19 pandemic—the Gulf Health Council (GHC) engaged Shift Health to develop a foundational strategic, operating and implementation plan for the Gulf Centre for Disease Control and Prevention.
The Saudi government sought to establish a national public health agency as a critical component of its efforts to transform the country’s entire health system.
The Saudi Government aimed to create a national health research agency to strengthen the research and innovation ecosystem, support a learning healthcare system and diversify the Kingdom’s knowledge economy.
Cancer research stakeholders across Canada recognized the need for a unifying vision that would inspire collective action and prepare Canada for leadership in a rapidly evolving cancer research landscape.
The Saskatchewan Centre for Patient-Oriented Research (SCPOR) needed a third-party evaluation to understand its impact to date and optimize its strategy.
The Pox-Protein Public-Private Partnership (P5) is tackling an enduring and daunting challenge: developing the world’s first HIV vaccine and ensuring it achieves maximum public health impact.
Ontario SPOR SUPPORT Unit (OSSU) needed to develop and pilot an evaluation tool to assess the impact of its multi-sectoral approach to patient-oriented research at the midpoint of its funding cycle.
The Canadian Cancer Research Alliance (CCRA) wanted to better understand the cancer clinical trial landscape in Canada, and in particular, the contribution of its initiatives to promoting access to trials.